Abyssomicins-A 20-Year Retrospective View

Mar Drugs. 2021 May 24;19(6):299. doi: 10.3390/md19060299.

Abstract

Abyssomicins represent a new family of polycyclic macrolactones. The first described compounds of the abyssomicin family were abyssomicin B, C, atrop-C, and D, produced by the marine actinomycete strain Verrucosispora maris AB-18-032, which was isolated from a sediment collected in the Sea of Japan. Among the described abyssomicins, only abyssomicin C and atrop-abyssomicin C show a high antibiotic activity against Gram-positive bacteria, including multi-resistant and vancomycin-resistant strains. The inhibitory activity is caused by a selective inhibition of the enzyme 4-amino-4-deoxychorismate synthase, which catalyzes the transformation of chorismate to para-aminobenzoic acid, an intermediate in the folic acid pathway.

Keywords: 4-amino-4-deoxychorismate synthase inhibitor; abyssomicins; chorismate pathway.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / metabolism
  • Anti-Bacterial Agents* / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic* / chemistry
  • Bridged Bicyclo Compounds, Heterocyclic* / metabolism
  • Bridged Bicyclo Compounds, Heterocyclic* / pharmacology
  • Fermentation
  • Humans
  • Micromonosporaceae / genetics
  • Micromonosporaceae / metabolism
  • Micromonosporaceae / ultrastructure

Substances

  • Anti-Bacterial Agents
  • Bridged Bicyclo Compounds, Heterocyclic

Supplementary concepts

  • Verrucosispora maris